Jason Richey brings 28 years of operational and commercial experience to the Allurion board. Most recently, Jason served as President and Chief Executive Officer of Cytrellis Biosystems, a Boston based medical device company with a breakthrough technology for skin rejuvenation created in partnership with Massachusetts General Hospital & Harvard Medical School. Prior to Cytrellis, Jason served as President and Chief Operating Officer of Cutera, Inc. a publicly traded, energy-based, aesthetic device company in northern California. Prior to Cutera, Jason served in a dual executive role for LivaNova, PLC., a London based, publicly traded, medical device company focused on cardiac surgery and neuromodulation. At LivaNova, Jason served as both President of the global Neuromodulation franchise and as President of North America. Throughout Jason's career, he has a proven track record of recruiting & developing top-talent, driving scalable and profitable top-line growth, responsible expense management, and delivering long-term value to shareholders. Jason holds a B.A. in Biology from Indiana University.